| 51.84 Real-Time Quote |  +0.03 / +0.06%Today’s Change | 40.59 Today|||52-Week Range 58.41 | +5.11% Year-to-Date |
| Sarissa's Stake in VIVUS Points to Renewed Interest in the Company 12:36pm / MotleyFool.com | Patent Challenge from Perrigo - Analyst Blog May 31 / Zacks.com |
| Pfizer's Big Chance 12:21pm / MotleyFool.com | Stocks Market News for May 30, 2013 - Market News May 30 / Zacks.com |
| Profiting from Diabetes Expenses Jun 05 / MotleyFool.com | Encouraging Data from Alkermes - Analyst Blog May 29 / Zacks.com |
| Celgene Presents Data at ASCO - Analyst Blog Jun 05 / Zacks.com | Smithfield fails to light up Wall St May 29 / FT.com |
| Eli Lilly's Alimta Disappoints - Analyst Blog Jun 04 / Zacks.com | Oncogenex to Advance OGX-427 Development - Analyst Blog May 24 / Zacks.com |
| Previous close | 51.81 |
| Today’s open | 51.81 |
| Day’s range | 51.34 - 52.43 |
| Volume | 2,599,076 |
| Average volume (3 months) | 5,001,299 |
| Market cap | $58.4B |
| Dividend yield | 3.79% |
| Earnings growth (last year) | -6.15% |
| Earnings growth (this year) | +15.88% |
| Earnings growth (next 5 years) | 0.00% |
| Revenue growth (last year) | -6.93% |
| P/E ratio | 12.4 |
| Price/Sales | 2.43 |
| Price/Book | 4.01 |
| Today’s change | Today’s % change | |
|---|---|---|
| ABTAbbott Laboratories | +0.30 | +0.83% |
| AZNAstraZeneca PLC | +0.46 | +0.91% |
| ABBVAbbVie Inc | +0.14 | +0.33% |
| CELGCelgene Corp | +1.25 | +1.11% |
| Next reporting date | July 24, 2013 |
| EPS forecast (this quarter) | $1.00 |
| Annual revenue (last year) | $22.6B |
| Annual profit (last year) | $4.1B |
| Net profit margin | 18.09% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
Chief Executive Officer, CFO & EVP-Global Services Derica W. Rice, MBA |
Vice President- Biotechnology Discovery Research Thomas F. Bumol, PhD |
Corporate headquarters Indianapolis, Indiana |
.
